Ultra-small phospholipid nanoparticles in the treatment of combined hyperlipidemia: a randomized placebo-controlled clinical trial

Ultra-small phospholipid nanoparticles in the treatment of combined hyperlipidemia: a randomized placebo-controlled clinical trial

Background and purpose: Combined hyperlipidemia is associated with an increased risk of cardiovascular events. This clinical trial investigated phospholipovit (essential phospholipids, Institute of Biomedical Chemistry, Moscow, Russia), an ultra-small phospholipid nanoparticle (micelles), targeted t...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexander Archakov, Valery Kukharchuk, Andrey Lisitsa, Elena Ponomarenko, Yulia Romashova, Tatiana Pleshakova, Elena Yarovaya, Vladimir Kutsenko, Maria Guseva, Valery Beregovykh, Olga Ipatova, Marina Zubareva, Elena Tikhonova, Sergei Ivanov, Farid Bedretdinov, Sergey Markin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Research in Pharmaceutical Sciences
Subjects:
combined hyperlipidemia
non-hdl-c
phospholipid nanoparticles (micelles)
tg
Online Access:https://journals.lww.com/10.4103/RPS.RPS_274_23
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/RPS.RPS_274_23

Similar Items